Use of vasopressors during esophagectomy is not associated with increased risk of anastomotic leak. Issue 4 (18th September 2020)

• Record Type: Journal Article
• Authors: Walsh, Kevin J; Zhang, Hao; Tan, Kay See; Pedoto, Alessia; Desiderio, Dawn P; Fischer, Gregory W; Bains, Manjit S; Jones, David R; Molena, Daniela; Amar, David
• Is Part Of: Diseases of the esophagus. Volume 34:Issue 4(2021)
• Publication Date: 2020-09-18
• Subjects: complications -- thoracic surgery -- esophagogastrectomy -- norepinephrine -- phenylephrine; Esophagus -- Diseases -- Periodicals; 616.32
• DOI: 10.1093/dote/doaa090
• Languages: English
• ISSNs: 1120-8694

Abstract

Summary: Vasopressor use during esophagectomy has been reported to increase the risk of postoperative anastomotic leak and associated morbidity. We sought to assess the association between vasopressor use and fluid (crystalloid and colloid) administration and anastomotic leak following open esophagectomy. Patients who underwent open Ivor Lewis esophagectomy were identified from a prospective institutional database. The primary outcome was postoperative anastomotic leak (any grade) and analyzed using logistic regression models. Postoperative anastomotic leak developed in 52 of 327 consecutive patients (16%) and was not significantly associated with vasopressor use or fluid administered in either univariable or multivariable analyses. Increasing body mass index was the only significant characteristic of both univariable ( P = 0.004) and multivariable analyses associated with anastomotic leak (odds ratio, 1.05; 95% confidence interval, 1.01–1.09; P = 0.007). Of the 52 patients that developed an anastomotic leak, 12 (23%) were grade 1, 21 (40%) were grade 2 and 19 (37%) were grade 3. In our cohort, only body mass index, and not intraoperative vasopressor use and fluid administration, was significantly associated with increased odds of postoperative anastomotic leak following open Ivor Lewis esophagectomy.